Patent · US Active

Assay for Chlamydia trachomatis by amplification and detection of Chlamydia trachomatis pmpA gene

US9416426B2 · kind B2 · utility

0Cited by
6References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2013
Grant dateAug 16, 2016
Priority date
Expiry dateAug 11, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A region of the Chlamydia trachomatis pmpA gene has been identified which is useful for performing amplification assays to determine specifically whether C. trachomatis is present in the sample being tested. Oligonucleotides useful for detecting this gene by performing the polymerase chain reaction (PCR) are disclosed. The disclosed oligonucleotides can be used in an assay which is specific for multiple strains or serovars of C. trachomatis, including the variant E serovar, and which does not show cross reactivity with the genomes of other microorganisms or with human DNA. In addition, the disclosed oligonucleotides can be used to in a multiplex system. This invention also contemplates a kit including oligonucleotides, and optionally other reagents, for the detection of C. trachomatis using PCR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.